Stifel lowered the firm’s price target on Bruker (BRKR) to $57 from $70 and keeps a Hold rating on the shares. Bruker continues to show ...
Barclays analyst Luke Sergott maintained a Buy rating on Bruker (BRKR – Research Report) today and set a price target of $60.00. The company’s ...
Bruker expects full-year earnings in the range of $2.67 to $2.72 per share, with revenue in the range of $3.47 billion to $3.54 billion. Bruker shares have fallen 12% since the beginning of the year.
16h
Hosted on MSNBruker Q4 Earnings & Revenues Surpass Estimates, Stock FallsBruker Corporation BRKR delivered adjusted earnings per share (EPS) of 76 cents for the fourth quarter of 2024, up 8.6% year ...
StockStory.org on MSN1d
Bruker’s (NASDAQ:BRKR) Q4 Sales Top Estimates But Full-Year Sales Guidance Misses ExpectationsScientific instrument company Bruker (NASDAQ:BRKR). reported Q4 CY2024 results , with sales up 14.6% year on year to $979.6 ...
Spatial Proteomics Market Spatial Proteomics Market Dublin, Feb. 11, 2025 (GLOBE NEWSWIRE) -- The "Spatial Proteomics Market ...
Bruker's minispec Whole Body Composition Analyzer based on TD-NMR provides a precise method for measurement of lean tissue, fat and fluid in living mice and rats. This body composition analyzer ...
timsTOF was engineered by Bruker experts as an open platform to accelerate the adoption of ion mobility-mass spectrometry analysis across research applications. All that is missing are your ...
After hours: February 13 at 5:04:50 PM EST Loading Chart for BRKR ...
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results